China defends measures amid growing criticism on 'zero-Covid policy'

China on Tuesday defended its coronavirus measures that reportedly have resulted in hardship in several Chinese cities including the global financial hub Shanghai.

China defends measures amid growing criticism on 'zero-Covid policy'
ANI US
2 min read Last Updated : Apr 13 2022 | 8:21 AM IST

Amid growing criticism over its zero-COVID policy, China on Tuesday defended its coronavirus measures that reportedly have resulted in hardship in several Chinese cities including the global financial hub Shanghai.

Speaking at the press conference on Tuesday, the Chinese Foreign Ministry Spokesperson Zhao Lijian said the country's "dynamic" zero-COVID policy and anti-epidemic protocols are based on science and expert opinions.

Zhao said the policies are also consistent with its national realities and the WHO's guiding principles.

"They have effectively protected the life and health of Chinese and foreign nationals living in China and made important contributions to the global fight against the pandemic. The international community, the WHO included, has spoken highly of them," he said.

This response comes as the European Union Chamber of Commerce in China said COVID lockdowns have caused "significant disruptions" for many companies. Nearly half of German firms said in a survey their supply chains have been impacted.

Further defending the country's COVID-19 policies, the Chinese spokesperson said some Chinese cities have adopted a host of prevention and control measures in response to sporadic outbreaks.

"Although these measures have had some impact on daily life and production, the effect is limited in both duration and scope. Thanks to such measures, the vast majority of the population in most regions can enjoy normal life and production,"

He said all prevention and control measures "come at a price." "All these efforts are worthwhile to protect people's life and health. Facts have proven that the overall guideline of dynamic zero-COVID is proper as it fits China's realities and has delivered desirable results.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusChinaShanghaiCoronavirus Tests

First Published: Apr 13 2022 | 8:20 AM IST

Next Story